Nov 01, 2022 / 12:30PM GMT
Operator
Hello, and welcome to the BioCryst Third Quarter 2022 Earnings Conference Call. My name is Michelle, and I will be your operator for today's conference. (Operator Instructions) As a reminder, the conference is being recorded.
I will now turn the call over to Mr. John Bluth with BioCryst. Sir, you may begin.
John D. Bluth - BioCryst Pharmaceuticals, Inc. - Chief Communications Officer
Thanks, Michelle. Good morning, and welcome to BioCryst's Third Quarter 2022 Corporate Update and Financial Results Conference Call. Today's press release and accompanying slides are available on our website. Participating with me today are CEO, Jon Stonehouse; CFO, Anthony Doyle; Chief Commercial Officer, Charlie Gayer; and Chief R&D Officer, Dr. Helen Thackray. Following our remarks, we will answer your questions.
Before we begin, please note that today's conference call will contain forward-looking statements, including those statements regarding future results, unaudited and forward-looking financial information as well as the company's future performance
Q3 2022 BioCryst Pharmaceuticals Inc Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot